Works by Farooq, Asim V.


Results: 32
    1
    2
    3
    4

    Atypical Keratitis Caused by .

    Published in:
    2021
    By:
    • Williams, Blake;
    • Jafri, Mansab;
    • Arfeen, Safa;
    • Reidy, James J.;
    • Hariprasad, Seenu M.;
    • Farooq, Asim V.
    Publication type:
    journal article
    5
    6

    Characterization of Belantamab Mafodotin–Induced Corneal Changes in Patients With Multiple Myeloma.

    Published in:
    JAMA Ophthalmology, 2025, v. 143, n. 6, p. 507, doi. 10.1001/jamaophthalmol.2025.1008
    By:
    • Lee, Vivian;
    • Hultcrantz, Malin;
    • Petrone, Stephanie;
    • Lewis, Eric W.;
    • Banna, Hussam;
    • Lichtman, Eben;
    • Thulasi, Praneetha;
    • Quick, Anjulie A.;
    • Jeng, Bennie H.;
    • Sunshine, Sarah B.;
    • Francis, Jasmine H.;
    • Canestraro, Julia;
    • Farooq, Asim V.;
    • Clements, Peter;
    • Robertson, Nicola;
    • Burman, Mark;
    • McKevitt, Tom;
    • Struemper, Herbert;
    • Weir, Lucinda
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00494-4
    By:
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Thulasi, Praneetha;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Potter, Heather A.;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Popat, Rakesh;
    • Degli Esposti, Simona;
    • Byrne, Julie;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Gupta, Ira;
    • Dana, Reza;
    • Farooq, Asim V.;
    • Colby, Kathryn;
    • Jakubowiak, Andrzej
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    The microbiome and ophthalmic disease.

    Published in:
    Experimental Biology & Medicine, 2019, v. 244, n. 6, p. 419, doi. 10.1177/1535370218813616
    By:
    • Baim, Adam D;
    • Movahedan, Asadolah;
    • Farooq, Asim V;
    • Skondra, Dimitra;
    • von Recum, Horst
    Publication type:
    Article
    21
    22
    23
    24
    25

    Herpesvirus Infections of the Corneal Endothelium.

    Published in:
    Microorganisms, 2025, v. 13, n. 4, p. 778, doi. 10.3390/microorganisms13040778
    By:
    • Wang, Jessie;
    • Rabiee, Behnam;
    • Patel, Chandani;
    • Jafri, Mansab;
    • Hussain, Hamad;
    • Chaudhry, Aaila;
    • Chaudhry, Imtiaz;
    • Kamoun, Layla;
    • Chaudhry, Iftikhar;
    • Oh, Lewis;
    • Bobat, Fatima I.;
    • Shukla, Deepak;
    • Farooq, Asim V.
    Publication type:
    Article
    26

    Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

    Published in:
    2020
    By:
    • Farooq, Asim V.;
    • Degli Esposti, Simona;
    • Popat, Rakesh;
    • Thulasi, Praneetha;
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Jakubowiak, Andrzej;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Byrne, Julie;
    • Gupta, Ira;
    • Colby, Kathryn
    Publication type:
    Correction Notice
    27

    Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody–Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

    Published in:
    Ophthalmology & Therapy, 2020, v. 9, n. 4, p. 889, doi. 10.1007/s40123-020-00280-8
    By:
    • Farooq, Asim V.;
    • Degli Esposti, Simona;
    • Popat, Rakesh;
    • Thulasi, Praneetha;
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Jakubowiak, Andrzej;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Byrne, Julie;
    • Gupta, Ira;
    • Colby, Kathryn
    Publication type:
    Article
    28
    29

    P-219: Relationship between corneal exam findings, best-corrected visual acuity, and ocular symptoms in patients with relapsed or refractory multiple myeloma receiving belantamab mafodotin.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S160, doi. 10.1016/S2152-2650(21)02346-6
    By:
    • Terpos, Evangelos;
    • Badros, Ashraf Z.;
    • Popat, Rakesh;
    • Rodríguez-Otero, Paula;
    • Farooq, Asim V.;
    • Jeng, Bennie;
    • Esposti, Simona Degli;
    • Lewis, Eric;
    • Gupta, Ira;
    • Opalinska, Joanna;
    • Palumbo, Antonio;
    • Trudel, Suzanne;
    • Jadhav, Vinay
    Publication type:
    Article
    30

    P-202: Characterization of ocular adverse events in patients receiving Belantamab Mafadotin for ≥12 months: post-hoc analysis of DREAMM-2 study in relapsed/refractory Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S149, doi. 10.1016/S2152-2650(21)02329-6
    By:
    • Lonial, Sagar;
    • Nooka, Ajay;
    • Thulasi, Praneetha;
    • Badros, Ashraf Z.;
    • Jeng, Bennie;
    • Callander, Natalie S.;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Popat, Rakesh;
    • Esposti, Simona Degli;
    • Baron, January;
    • Doherty, Allison;
    • Lewis, Eric;
    • Opalinska, Joanna;
    • Prani Paka;
    • Piontek, Trisha;
    • Gupta, Ira;
    • Farooq, Asim V.;
    • Jakubowiak, Andrzej
    Publication type:
    Article
    31

    MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S419, doi. 10.1016/S2152-2650(21)01940-6
    By:
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Thulasi, Praneetha;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Popat, Rakesh;
    • Esposti, Simona Degli;
    • Baron, January;
    • Doherty, Allison;
    • Lewis, Eric;
    • Opalinska, Joanna;
    • Paka, Prani;
    • Piontek, Trisha;
    • Gupta, Ira;
    • Farooq, Asim V.;
    • Jakubowiak, Andrzej
    Publication type:
    Article
    32

    Poster: MM-078: Characterization of Ocular Adverse Events in Patients Receiving Belantamab Mafodotin (Belamaf) for ≥ 12 Months: Post Hoc Analysis of DREAMM-2 Study in Relapsed/Refractory Multiple Myeloma (RRMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S251, doi. 10.1016/S2152-2650(21)01576-7
    By:
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Thulasi, Praneetha;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Popat, Rakesh;
    • Esposti, Simona Degli;
    • Baron, January;
    • Doherty, Allison;
    • Lewis, Eric;
    • Opalinska, Joanna;
    • Paka, Prani;
    • Piontek, Trisha;
    • Gupta, Ira;
    • Farooq, Asim V.;
    • Jakubowiak, Andrzej
    Publication type:
    Article